2073 related articles for article (PubMed ID: 17555006)
1. [Early detection of psychotic disorders].
Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
[TBL] [Abstract][Full Text] [Related]
2. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
[TBL] [Abstract][Full Text] [Related]
3. Early detection and intervention of psychosis. A review.
Salokangas RK; McGlashan TH
Nord J Psychiatry; 2008; 62(2):92-105. PubMed ID: 18569772
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
Mittal VA; Neumann C; Saczawa M; Walker EF
Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
[TBL] [Abstract][Full Text] [Related]
5. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
Carpenter WT; Bustillo JR; Thaker GK; van Os J; Krueger RF; Green MJ
Psychol Med; 2009 Dec; 39(12):2025-42. PubMed ID: 19796428
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive growth charting in psychosis spectrum youths.
Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
[TBL] [Abstract][Full Text] [Related]
7. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
8. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
Lecardeur L; Meunier-Cussac S; Dollfus S
Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
Faridi K; Pawliuk N; King S; Joober R; Malla AK
Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
[TBL] [Abstract][Full Text] [Related]
10. [Prodromes of schizophrenia: consensus or confusion?].
Teyssier JR
Encephale; 2013 May; 39 Suppl 1():S1-7. PubMed ID: 23351932
[TBL] [Abstract][Full Text] [Related]
11. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis.
Rosen C; Marvin R; Reilly JL; Deleon O; Harris MS; Keedy SK; Solari H; Weiden P; Sweeney JA
Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):145-51. PubMed ID: 23006239
[TBL] [Abstract][Full Text] [Related]
12. Treating young individuals at clinical high risk for psychosis.
Marshall C; Addington J; Epstein I; Liu L; Deighton S; Zipursky RB
Early Interv Psychiatry; 2012 Feb; 6(1):60-8. PubMed ID: 21951980
[TBL] [Abstract][Full Text] [Related]
13. [Is there any point in detecting high risk factors prior to a first psychosis?].
Klaassen MC; Nieman DH; Becker HE; Linszen DH
Tijdschr Psychiatr; 2006; 48(6):467-76. PubMed ID: 16956006
[TBL] [Abstract][Full Text] [Related]
14. [Challenges in the early detection of psychosis in children and adolescents].
Fiori Nastro P; Schimmelmann BG; Gebhardt E; Monducci E; Resch F; Koch E; Schultze-Lutter F
Riv Psichiatr; 2012; 47(2):116-25. PubMed ID: 22622248
[TBL] [Abstract][Full Text] [Related]
15. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
[TBL] [Abstract][Full Text] [Related]
16. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
[TBL] [Abstract][Full Text] [Related]
17. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
18. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
19. The significance of at-risk symptoms for psychosis in children and adolescents.
Schimmelmann BG; Walger P; Schultze-Lutter F
Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
[TBL] [Abstract][Full Text] [Related]
20. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.
Mees L; Zdanowicz N; Reynaert C; Jacques D
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S118-22. PubMed ID: 21894117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
